글로벌 심장독성 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 심장 독성 치료 시장

글로벌 심장독성 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 상기 연구 예측 기간 동안 CAGR 8.10%로 성장하고 있다고 분석합니다. 신흥 시장과 연구 개발에 대한 막대한 투자가 이 시장의 성장을 책임지는 요인입니다.

그러나 암의 유병률이 급격히 증가하고 화학 요법으로 유발된 심장 독성의 성장이 증가하면서 글로벌 심장 독성 치료 시장이 성장하고 있습니다. 게다가, 많은 건강 문제가 연령 증가와 관련이 있으며, 심혈관 질환이 증가하고 노인 인구가 증가하면서 시장 성장도 촉진됩니다. 개발도상국의 의료비 지출이 증가하면서 시장에서 기회가 생깁니다. 그러나 매우 저소득 국가의 인식 부족과 심장 독성 치료를 위한 약물의 부족으로 글로벌 심장 독성 치료 시장이 방해를 받을 수 있습니다.

심장독성은 심장 근육과 조직에 손상이 생기는 상태로, 그 결과 심장이 몸 전체에 혈액을 고르게 펌핑할 수 없게 됩니다. 항암제와 다른 약물로 인해 심장독성이 심하면 심근병으로 이어집니다. 심장독성과 관련된 증상은 흉통, 심박수 변화, 심방세동, 좌심실 박출률 감소, 심한 경우 울혈성 심부전 등입니다.

This cardiotoxicity treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Cardiotoxicity Treatment Market Scope and Market Size

The cardiotoxicity treatment market is segmented on the basis of type, causes, diagnosis, treatment end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the cardiotoxicity treatment market is segmented into cardiomyopathy, myocarditis, pericarditis, acute coronary syndromes, congestive heart failure and others.
• On the basis of causes, the cardiotoxicity treatment market is segmented into chemotherapy, targeted therapy, radiation therapy and others.
• On the basis of diagnosis, the cardiotoxicity treatment market is segmented into physical examination, chest X-ray, echocardiogram, ECG, MUGA, troponin blood tests and others.
• On the basis of treatment, the cardiotoxicity treatment market is segmented into medication and others. Medication segmented further divided into Dexrazoxane hydrochloride, ACE Inhibitors, Beta Blockers, diuretics, digoxin, vasodilators and others.
• On the basis of end-users, the cardiotoxicity treatment market is segmented into hospitals, specialty clinics and others.
• On the basis of distribution channel, the cardiotoxicity treatment market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Cardiotoxicity Treatment Market Country Level Analysis

Cardiotoxicity treatment market is analysed and market size information is provided by country, type, causes, diagnosis, treatment, end-users and distribution channel as referenced above.

The countries covered in the cardiotoxicity treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the increased research and development and well established healthcare facilities. Europe accounts the second largest market share due to increased cancer diseases. Asia-Pacific is expected to account for the largest market share over coming years for the cardiotoxicity treatment market due to increased geriatric population as well as growing healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cardiotoxicity treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Cardiotoxicity Treatment Market Share Analysis

Cardiotoxicity treatment market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to cardiotoxicity treatment market.

심장독성 치료 시장에서 다루는 주요 업체는 Terumo Cardiovascular Systems Corporation, Medtronic, Boston Scientific Corporation, Biotronik, Liva Nova, CR Bard, Becton Dickson Company, Cardinal Health Inc., Abbott, Johnson & Johnson Services, Inc., Cook Medical 등 국내 및 글로벌 업체입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60743